BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 8.01.2025

Developing Drugs for Optical Imaging; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Developing Drugs for Optical Imaging." The purpose of this guidance is to provide recommendations to sponsors regarding clinical trial design features that support development and approval of optical imaging drugs that are used in conjunction with imaging devices and intended as intraoperative aids for the detection of pathology such as tumors or to enhance the conspicuity of normal anatomical structures.

Source: Federal Register — Food and Drug AdministrationOpen original release →